Caveney Brian J 4

What Happened

• Brian J. Caveney, an EVP (Pres of ED, CMO & CSO) at Labcorp Holdings, was awarded two equity grants on February 10, 2026: 6,100 employee stock options and 2,020 restricted stock units (RSUs). Both grants are reported as acquired at $0.00 (typical for awards).
• The 6,100 item is an employee stock option (a right to buy company shares under the company's 2025 Omnibus Incentive Plan). The 2,020 item represents RSUs (each unit is a contingent right to receive one share upon vesting). These are grants (awards), not open-market purchases or sales.

Key Details

• Transaction date: 2026-02-10; Form 4 filed 2026-02-12 (appears filed within the usual two-business-day window).
• Reported prices: $0.00 (grant price) — this indicates an award/grant, not a cash purchase or sale. The option exercise/strike price is not specified in the summary provided.
• Vesting: Options vest in three equal annual installments beginning on the date shown in the filing; RSUs vest in three equal annual installments beginning February 10, 2027 (per footnotes).
• Shares owned after transaction: not specified in the provided summary (the filing should be checked for aggregate holdings if needed).
• Footnotes: F1 = employee stock option grant under 2025 Omnibus Incentive Plan; F2 = option vests in three equal annual installments; F3 = each RSU equals right to one share; F4 = RSU vesting begins 2/10/2027; F5 = 2,020 reflects aggregate RSUs held by the reporting person.

Context

• These are compensation awards (one option grant and RSUs) — common for executive retention/incentive. Options give a future right to buy shares (a derivative); RSUs convert to actual shares only as they vest.
• Awards are not immediate purchases or sales and do not necessarily indicate immediate bullish or bearish trading by the insider. For monetary impact or potential dilution, check the option strike price and total outstanding shares in the full filing or company disclosures.